Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-08-23
Original SEC Filing: Click here

---

Webplus: SKBI/20110823/8-K/2_EX-99.1/000.htm SEC Original: v233143_ex99-1.htm
NEWS RELEASEystar Bio-Pharmaceutical Reports Second Quarter 2011 Results $9.1 Million Top Line; $0.21 Diluted EPS; Expanded Direct Distribution andles Channels XIAN, CHINA August 23, 2011 — -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) (“Skystar” or the “Company”), Second Quarter 2011 Highlights Revenuereases 10% YoY to $9.1 million Veterinary vaccines totaled $0.4million, up 1.2% YoY

---

---

Webplus: SKBI/20110823/8-K/1/000.htm SEC Original: v233143_8k.htm
FORM 8-K CURRENT REPORTte of report (Date of earliest event reported):August 23, 2011 (August 22, 2011)YSTAR BIO-PHARMACEUTICALMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employer Identification No.) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2011-08-23CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE